XVIVO Perfusion AB (publ) Report on operations 2018
THE YEAR ENDED WITH CONTINUED STRONG GROWTH AND GOOD EBITDAFOURTH QUARTER 2018 (OCT - DEC) · Total net sales in the quarter amounted to SEK 58.4 (41.6) million, corresponding to an increase of 40 percent in SEK and 33 percent in local currency. Net sales of non-durable goods* in the quarter amounted to SEK 52.3 (39.4) million, corresponding to an increase of 33 percent in SEK and 26 percent in local currency. · Warm perfusion sales of non-durable goods** showed a record growth of more than 50 percent during the quarter. Sales from warm perfusion represented 50 percent (43) of sales